The Latest in T Cell Lymphomas

VIDEO: How to prepare PTCL patients for transplant

March 27, 2018

FDA updates breast implant–associated lymphoma cases, risk

March 22, 2018

Best options for treating relapsed/refractory PTCL

March 8, 2018

Mycosis fungoides increases risk for second cancers

February 28, 2018

Basiliximab/BEAM may improve post-ASCT outcomes in PTCL

February 21, 2018

A view from the bridge to transplant for PTCL

February 14, 2018

Getting hematologic cancer drugs on the fast track

February 9, 2018

T-cell lymphoma therapies on the horizon

February 9, 2018

MAVORIC: Mogamulizumab tops vorinostat in pretreated CTCL

December 10, 2017

FDA approves brentuximab vedotin for primary cutaneous anaplastic large cell lymphoma

November 9, 2017

T Cell Lymphomas

Study shows childhood IBD increased cancer risk in adulthood

September 27, 2017

Phase III trial: VZV protects auto-HCT patients

February 25, 2017

Neuropathic pain puts cancer survivors out of work

February 5, 2017

Brentuximab vedotin beat methotrexate, bexarotene in cutaneous T-cell lymphoma

December 6, 2016

T Cell Lymphomas

‘Meaningful’ antitumor activity with lenalidomide monotherapy in ATL

September 20, 2016

T Cell Lymphomas